Forward Ventures logo

Forward Ventures

North America, California, United States, San Diego

Description

Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.

Investor Profile

Forward Ventures has made 63 investments, with 1 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (29%)
  • Series A (24%)
  • Series C (19%)
  • Series D (14%)
  • Series Unknown (6%)
  • Series E (3%)
  • Undisclosed (2%)
  • Debt Financing (2%)
  • Seed (2%)

Country Focus

  • United States (94%)
  • United Kingdom (5%)
  • Canada (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Medical Device
  • Clinical Trials
  • Women's
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Forward Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 8
Domain Associates
North America, California, United States, San Diego
Co-Investments: 13
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 6
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 7
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 7
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 9
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Enterprise Partners
North America, California, United States, La Jolla
Co-Investments: 5

Which angels does Forward Ventures often collaborate with?

TD
North America, California, United States, San Francisco
Shared Deals: 1
TH
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by Forward Ventures?

Speckle

London, England, United Kingdom

Speckle is a collaborative data hub that connects various AEC (Architecture, Engineering, and Construction) tools.

ConstructionOpen SourceSoftware
Series AOct 25, 2024
Amount Raised: $12,500,000
Xanadu

Toronto, Ontario, Canada

Xanadu provides hardware, software, applications, and simulators for quantum computing.

Big DataHardwareQuantum ComputingSoftware
Series CNov 9, 2022
Amount Raised: $100,000,000
Virtuoso

London, England, United Kingdom

Virtuoso is a software development company that develops codeless test automation software.

Information ServicesInformation TechnologyMobileQuality AssuranceSoftwareWeb Development
SeedAug 20, 2019
Amount Raised: $3,250,000
Viracta Therapeutics

Cardiff By The Sea, California, United States

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series BApr 4, 2017
Amount Raised: $18,400,000
Syndax Pharmaceuticals

Waltham, Massachusetts, United States

Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series CAug 24, 2015
Amount Raised: $80,000,000
Affinium Pharmaceuticals

Austin, Texas, United States

Affinium Pharmaceuticals is a specialty pharmaceutical company, focused on the development of novel anti-infective medicines.

BiotechnologyHealth CarePharmaceutical
Debt FinancingSep 11, 2013
Amount Raised: $11,900,000
Syndax Pharmaceuticals

Waltham, Massachusetts, United States

Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series BAug 27, 2013
Amount Raised: $26,600,000
Ambit Biosciences

San Diego, California, United States

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

BiopharmaBiotechnologyHealth Care
Series UnknownNov 6, 2012
Amount Raised: $50,000,000
Viracta Therapeutics

Cardiff By The Sea, California, United States

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series BMar 12, 2012
Amount Raised: $13,000,000
Affinium Pharmaceuticals

Austin, Texas, United States

Affinium Pharmaceuticals is a specialty pharmaceutical company, focused on the development of novel anti-infective medicines.

BiotechnologyHealth CarePharmaceutical
Series BAug 29, 2011
Amount Raised: $15,000,000